2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) is a photosensitiser chemical that is used in photodynamic therapy.
It is being developed under the brand name Photochlor.
Clinical trials A phase I/II clinical trial started in 1997 for esophageal cancer.Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
A phase II trial for non-small cell lung cancer is due to run from 2007 to 2011.Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages
References
External links Clinical trials of HPPH